Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.52 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | FPR2 | P25090 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5134972 | 0.94 | FAAH (0.52) | FAAHC5AR1HDAC1TP53TSHR | |
| SCHEMBL650694 | 0.86 | TSHR (0.51) | C5AR1HDAC1TSHRKDM4EALDH1A1 | |
| SCHEMBL5135779 | 0.85 | TSHR (0.44) | C5AR1HDAC1TSHRKDM4EALDH1A1 | |
| SCHEMBL5072206 | 0.84 | FAAH (0.42) | FAAHC5AR1HDAC1TSHR | |
| SCHEMBL5135950 | 0.81 | LPAR1 (0.42) | C5AR1HDAC1KDM4EALDH1A1GAA | |
| SCHEMBL5135893 | 0.81 | TLR7 (0.49) | C5AR1 | |
| SCHEMBL650439 | 0.81 | FAAH (0.48) | FAAHTSHRKDM4EALDH1A1HPGD | |
| SCHEMBL649161 | 0.80 | C5AR1 (0.47) | C5AR1TSHRKDM4EALDH1A1HPGD | |
| SCHEMBL649871 | 0.79 | C5AR1 (0.42) | FAAHC5AR1HDAC1KDM4EHPGD | |
| SCHEMBL1913014 | 0.79 | C5AR1 (0.42) | FAAHC5AR1HDAC1TP53TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490044-A4 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORP (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1490044-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003084524-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2003-10-16 | — | — | WO | disclosed |